Subscribe
24 April 2025FeaturesEuropeAgathe Michel-de Cazotte & Ben Chapman

Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO

Following the Unified Patent Court’s recent Meril v Edwards decision, Agathe Michel-de Cazotte & Ben Chapman of Carpmaels & Ransford examine the court’s treatment of obviousness to date.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Failure to make findings of fact adds twist to battle over Eliquis in Ireland
15 April 2025   A new High Court judge will be tasked with the “massive decision” on the plausibility of Bristol Myers Squibb’s key anticoagulant patent, following its appeal over failures in the previous trial, say Eoin Martyn and Hannah Garvey of Taylor Wessing.
Europe
UPC issues sweeping injunction against Meril in heart valve case
8 April 2025   The court hands Edwards Lifesciences a win in its long-running battle with Meril | Panel issues a second Europe-wide injunction over prosthetic heart valve technology | Judges reject Meril’s latest attempt to invalidate Edwards’ patent.
Unified Patent Court
Sanofi and Regeneron triumph in UPC decision against Amgen
16 July 2024   UPC’s Munich Central Division revokes Amgen's patent | Decision stems from a revocation action initiated by Sanofi last year | Court's ruling focused on interpretations of patent claims and principles of inventive step.


Editor's picks

Killing the golden goose of US drug innovation (Part II): Drug pricing myths
Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025

Editor's picks

Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
3 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
2 September 2025
Europe
UPC sees rising small molecule litigation with Pfizer in the hot seat
29 August 2025
Europe
Astellas win strengthens blockbuster drug's European position
20 August 2025

More features

AIPPI: Personalised medicine tests the limits in patent law
Ropes & Gray loses 21-attorney group to join rival on growth spree
How 'Boehringer' sets preliminary relief threshold for generics
‘Whose trademark law is AI based on exactly?’: Key questions from Marques
To disclose or not: Pharma patents face new AI reality
Trade secrets go global: How brand owners face a high-stakes battlefront
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
Killing the golden goose of US drug innovation (Part I): Follow the money